Biopharmaceutical company GSK plc (LSE/: GSK ) (NYSE: GSK) announced on Wednesday that it has awarded USD2m in grant funding to 15 public health organisations through its COiMMUNITY Initiative, supporting efforts to improve adult immunization education, outreach and access.

Notable recipients include the American Heart Association, the Sepsis Alliance and the National Council on Aging, each addressing immunisation gaps in unique ways.

In 2025, GSK will commit an additional USD2m to further enhance vaccine awareness and accessibility.

Since launching in 2023, the COiMMUNITY Initiative has provided USD3m in funding to nonprofits nationwide, reinforcing GSK's commitment to overcoming barriers to adult immunization in the US.